To what extent does pharmaceutical company research in South Africa reflect the countries burden of disease?
Student Number : 0310496H - MPH research report - Faculty of Health Sciences === This study compares pharmaceutical company research on new medicines in South Africa with the country’s burden of disease and describes the process and criteria that companies use to set their research priorities. A q...
Main Author: | Hoerter, Jeanne |
---|---|
Format: | Others |
Language: | en |
Published: |
2006
|
Subjects: | |
Online Access: | http://hdl.handle.net/10539/1870 |
Similar Items
-
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
by: Ye Lim Jung, et al.
Published: (2020-09-01) -
The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence
by: Nivantha Naidoo, et al.
Published: (2020-01-01) -
Exploring why global health needs are unmet by research efforts: the potential influences of geography, industry and publication incentives
by: Alfredo Yegros-Yegros, et al.
Published: (2020-05-01) -
Evaluating the reliability and accuracy of the promotional brochures for the generic pharmaceutical companies in Iraq using World Health Organization guidelines
by: Ehab Mudher Mikhael
Published: (2015-01-01) -
The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research
by: Ye Lim Jung, et al.
Published: (2019-12-01)